Bupivacaine Injection, Solution
Product Images NDC 0409-3613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bupivacaine (NDC 0409-3613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Bupivacaine 01)

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Bupivacaine 02)

FDA Label Image

Structural Formula Dextrose (Bupivacaine 03)

FDA Label Image

Hospira Logo (Bupivacaine 04)

FDA Label Image

Principal Display Panel (2 mL Ampule Label)

Principal Display Panel (2 mL Ampule Label)
This is a label for Bupivacaine HCI 0.75% solution, with a concentration of 5 mg in 2 mL or 7.5 mg/mL. The label includes a barcode and lot number with an expiration date.*
FDA Label Image

Principal Display Panel (10 Ampule Carton Label)

Principal Display Panel (10 Ampule Carton Label)
This is a single-dose hyperbaric solution used for spinal anesthesia containing 15mg/2mL of Bupivacaine HCI and Dextrose 8.25% USP injection. The container comes in 10 ampuls with usual dosage prescribed as per the insert. It is advised to store at a temperature of 20-25°C but permitted between 15 to 30°C. It is sterile and the pH is adjusted to between 4.0 and 6.5 with NaOH or HCI. The specific gravity is between 1.030 and 1.035 at 25°C and 1.03 at 37°C. Lot information is provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.